I encourage patients to approach claims about BPC-157 with informed optimism, recognizing the real promise while understanding the very real limitations of our current knowledge
Worked Example 3: Retatrutide 10mg with 2mL Bacteriostatic Water Retatrutide 10mg with 2mL bacteriostatic water: Peptide mass: 10mg Bacteriostatic water: 2mL Concentration: 10mg 2mL = 5 mg/mL Peptide per unit: 5 mg 100 = 0.05 mg/unit = 50 mcg/unit Research units needed per protocol (varies by protocol): depends entirely on research design Total doses per vial depend on per-dose research amount For a 2mg research unit: 10mg 2mg = 5 research doses per vial For a 4mg research unit: 10mg 4mg = 2.5 research doses per vial This is why retatrutide pricing on a per-research-unit basis varies significantly depending on research protocol design
Ruenzi et al., 2005) and in experimental rat studies (see Duzel et al., 2017), and has very safe profile (LD1 could be not achieved) (Seiwerth et al., 2018), a point recently confirmed (Xu et al., 2020)
These temperature-sensitive peptide medicationsincluding semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)require specific storage conditions to maintain therapeutic effectiveness
We will not recommend a human dose but we can show what a vial of each format yields: Cross-check the published preclinical doses in our SLU-PP-332 Dosing Guide before committing to any format